WO2014118385A8 - Utilisation de séquences d'adn codant pour un interféron en tant qu'adjuvants de vaccin - Google Patents

Utilisation de séquences d'adn codant pour un interféron en tant qu'adjuvants de vaccin Download PDF

Info

Publication number
WO2014118385A8
WO2014118385A8 PCT/EP2014/052111 EP2014052111W WO2014118385A8 WO 2014118385 A8 WO2014118385 A8 WO 2014118385A8 EP 2014052111 W EP2014052111 W EP 2014052111W WO 2014118385 A8 WO2014118385 A8 WO 2014118385A8
Authority
WO
WIPO (PCT)
Prior art keywords
interferon
dna sequences
sequences encoding
vaccine adjuvants
vaccine
Prior art date
Application number
PCT/EP2014/052111
Other languages
English (en)
Other versions
WO2014118385A1 (fr
Inventor
Børre ROBERTSEN
Chia Jung Chang
Original Assignee
University of Tromsø
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50031356&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2014118385(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of Tromsø filed Critical University of Tromsø
Priority to EP14702282.6A priority Critical patent/EP2950816B1/fr
Publication of WO2014118385A1 publication Critical patent/WO2014118385A1/fr
Publication of WO2014118385A8 publication Critical patent/WO2014118385A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne l'utilisation de séquences codant pour un interféron de type I, la prévention et la lutte de troubles pathologiques chez les poissons d'élevage.
PCT/EP2014/052111 2013-02-04 2014-02-04 Utilisation de séquences d'adn codant pour un interféron en tant qu'adjuvants de vaccin WO2014118385A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP14702282.6A EP2950816B1 (fr) 2013-02-04 2014-02-04 Utilisation de séquences d'adn codant pour un interféron en tant qu'adjuvants de vaccin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20130175 2013-02-04
NO20130175 2013-02-04

Publications (2)

Publication Number Publication Date
WO2014118385A1 WO2014118385A1 (fr) 2014-08-07
WO2014118385A8 true WO2014118385A8 (fr) 2015-04-09

Family

ID=50031356

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2014/052111 WO2014118385A1 (fr) 2013-02-04 2014-02-04 Utilisation de séquences d'adn codant pour un interféron en tant qu'adjuvants de vaccin

Country Status (2)

Country Link
EP (1) EP2950816B1 (fr)
WO (1) WO2014118385A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2017002897A1 (es) * 2017-11-14 2018-04-20 Univ De Santiago De Chile 10% Bacteria lactococcus lactis transformada, productora de interferón gamma (ifng) de salmo salar, alimento y composición que la comprende, para inmunoestimular especies acuícolas.
CN113476599B (zh) * 2021-07-05 2023-08-22 山东省淡水渔业研究院（山东省淡水渔业监测中心） 疫苗免疫增强剂重组IFNγ、IL-1β及TNFα及其制备方法和应用
WO2023122526A1 (fr) 2021-12-20 2023-06-29 Zoetis Services Llc Utilisation d'interferon comme adjuvant dans des vaccins

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002060921A2 (fr) * 2000-11-09 2002-08-08 Board Of Trustees Of The University Of Illinois Facilitation de la reponse immunitaire au vaccin au moyen de l'interferon alpha
NO20033000D0 (no) 2003-06-30 2003-06-30 Boerre Robertsen Gensekvenser kodende for interferon fra laks og behandling av laksefisk medrekombinant lakseinterferon for beskyttelse mot virus-infeksjon
FI116068B (fi) 2003-09-15 2005-09-15 Fit Biotech Oyj Plc Uusi selektiojärjestelmä, siinä käyttökelpoinen vektori, bakteerisolukantoja sekä menetelmä solujen valikoimiseksi
ES2247942B1 (es) 2004-08-27 2006-10-01 Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria (Inia) Construccion genica, vector y vacuna adn para la vacunacion de animales acuaticos.
WO2006099451A2 (fr) * 2005-03-14 2006-09-21 University Of Medicine & Dentistry Of New Jersey Nouveaux interferons provenant des etres humains, des felins, des volailles et d'autres especes animales et leurs utilisations
DK179025B1 (da) 2005-09-16 2017-08-28 Intervet Int Bv Fiskevaccine
CN101495636B (zh) 2006-04-13 2012-12-05 国立大学法人东京海洋大学 锦鲤疱疹病毒（khv）病用dna疫苗
WO2009002376A1 (fr) 2007-06-26 2008-12-31 The United States Of America, As Represented By The Secretary Of The Interior, Washington, D.C. On Behalf Of The United States Geological Survey Vaccin à adn contre le virus de la virémie printanière nord américaine de la carpe
EP2231698B9 (fr) 2007-12-19 2014-10-29 Intervet International BV Antigènes de vaccin provenant de la piscirickettsia salmonis
JP5660039B2 (ja) 2009-06-30 2015-01-28 日本ゼオン株式会社 熱伝導性感圧接着剤組成物、熱伝導性感圧接着性シート、及び電子部品
US8750265B2 (en) 2009-07-20 2014-06-10 Wefi, Inc. System and method of automatically connecting a mobile communication device to a network using a communications resource database
US20120297948A1 (en) 2011-05-23 2012-11-29 George Allen Kenton Method to supply water to tile saw blade

Also Published As

Publication number Publication date
EP2950816B1 (fr) 2019-07-31
WO2014118385A1 (fr) 2014-08-07
EP2950816A1 (fr) 2015-12-09

Similar Documents

Publication Publication Date Title
MD4733C1 (ro) Anticorpi anti-TIGIT
WO2015085318A3 (fr) Vaccins adaptatifs ciblés
HK1223628A1 (zh) β- 新的 -酮- β-烷基膽烷酸衍生物在製備奧貝膽酸以及其在醫藥領域的用途
RS57316B1 (sr) Sinergističko poboljšanje isporuke nukleinskih kiselina pomoću mešavina formulacija
PH12015502216A1 (en) Compositions and methods for improving the health of aquatic animals
EP2991670B8 (fr) Utilisation de sobétirome dans le traitement de maladies associées à la myélinisation
EP3130582B8 (fr) Composé ayant un effet thérapeutique sur les maladies immunitaires et utilisation de ce composé
EP3134423A4 (fr) Analogues de nucléosides disubstitués en 2' pour le traitement des virus de la famille des flaviviridae et du cancer
HK1256033A1 (zh) 用於刺激免疫系統的肽
WO2014127378A8 (fr) Conception d'oligonucléotides courts en tant qu'adjuvants de vaccin et agents thérapeutiques
AU344383S (en) Fishing lure
EP3228626A4 (fr) Peptide à activité permettant d'améliorer l'état de la peau, et son utilisation
GB201404403D0 (en) Compositions and methods relating to the treatment of diseases
IL257194B (en) Targeted delivery of spray-dried formulations to the lungs
HK1221390A1 (zh) 關於造影劑施用的方法和工具
WO2014118385A8 (fr) Utilisation de séquences d'adn codant pour un interféron en tant qu'adjuvants de vaccin
HK1205147A1 (en) Truncated l1 proteins of human papillomavirus type 45 45 l1
WO2015038891A3 (fr) Analogues peptidiques fonctionnels du pedf
HK1223857A1 (zh) 鑒定對腫瘤具有直接抑制作用的干擾素的方法及其用途
WO2016075305A3 (fr) Peptides dérivés d'acinetobacter baumannii et leur utilisation en vaccination
EP3105245A4 (fr) Peptides qui bloquent le recrutement des leucocytes, et procédés d'utilisation
HK1248595A1 (zh) 改善視覺的基因療法
SG11201509640RA (en) Use of an isopropanol-containing solution to combat calciviridae
GB201516437D0 (en) Compositions and methods relating to the treatment of disease
SG10201509440VA (en) HELISPORK - Utensil aiding SCI people to eat with comfort

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14702282

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase in:

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2014702282

Country of ref document: EP